PKD1 and neoplasm: One explanation might be the fact that while loss of Pkd1 is growth-inhibitory in a cell-autonomous manner in vitro, factors in the nascent tumor microenvironment—perhaps mediated by immune system components—ameliorate this effect in vivo.